Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on Orthocell’s (ASX:OCC) medical device sales in Singapore on the appointment of an exclusive distributor.

Its Remplir product is used in the repair of peripheral nerve injuries, where the global market is estimated to exceed US$3.5B. 

Tune in to get the latest.

 

While Orthocell is a Stockhead advertiser, it did not sponsor this content.

Read MoreHealth

Featured Companies

You might be interested in